Intrommune Therapeutics reported raising $210,000 in an initial SEC Form D filing, from an offering of $10 Million
Round Type
Seed
New YorkBiotechnologyHealth CareWho else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Intrommune Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Epicore Biosystems raised $26M (Series A) on January 19, 2024.
- Calidi Biotherapeutics raised $10K on January 19, 2024.
- FOXO Technologies raised $3.5M on January 19, 2024.
- Lynch Regenerative Medicine raised $3.8M (Seed) on January 17, 2024.
- Cleveland Diagnostics raised $75M (Funding Round) on January 17, 2024.
- Ratio Therapeutics raised $50M (Series B) on January 17, 2024.
Who to call at Intrommune Therapeutics, Inc., and when
A new round usually means Intrommune Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Intrommune Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Intrommune Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Intrommune Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Intrommune Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Intrommune Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.